Big pharma reaps big profits from single drugs

08/21/2013 | Quartz

Of the world's 11 largest pharmaceutical companies, six market a single drug that represented more than 10% of their total sales last year, according to journalist David Yanofsky. The company with the biggest portion of net sales in one drug was Abbott Laboratories with its rheumatoid arthritis treatment Humira, which accounted for more than 23% of the firm's sales, followed by Eli Lilly & Co., whose antidepressant Cymbalta made up more than 22% of net sales. The big exception: highly diversified Bayer, with no single product taking more than 5% of sales.

View Full Article in:

Quartz

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC